AiDing Diuresis wIth Tolvaptan (ADD-IT)

Trial Profile

AiDing Diuresis wIth Tolvaptan (ADD-IT)

Phase of Trial: Phase I

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Oedema
  • Focus Therapeutic Use
  • Acronyms ADD-IT
  • Most Recent Events

    • 12 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Mar 2018.
    • 12 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Mar 2018.
    • 15 Feb 2016 Status changed from not yet recruiting to recruiting, according to record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top